氧疗预处理对肾功能不全患者造影剂肾病的预防作用
这项随机对照研究纳入200例估算肾小球滤过率低于60 ml/min/1.73 m²的择期心血管造影患者,比较造影前纯氧(2 L/min)吸入10分钟与对照组的造影剂肾病发生率。结果显示氧疗组造影剂肾病发生率显著低于对照组(1% vs. 8%),提示围手术期氧疗可能是一种简单有效的非药物预防策略。
要点
- 择期心血管造影前吸入纯氧10分钟可降低肾功能不全患者造影剂肾病风险。
- 氧疗组造影剂肾病发生率为1%,显著低于对照组的8%。
- 贫血与未接受氧疗均与造影剂肾病发生独立相关。
核心结论
- 对于肾功能不全患者,造影前氧疗可能降低造影剂肾病发生率。
研究设计与样本
- 随机对照研究,共纳入200例估算肾小球滤过率低于60 ml/min/1.73 m²的择期心血管造影患者,氧疗组与对照组各100例。
主要发现
- 氧疗组动脉血氧分压高于对照组(135 ± 25 mm Hg vs. 84 ± 10 mm Hg,P < 0.001)。
- 氧疗组造影剂肾病发生率低于对照组(1% vs. 8%,OR = 0.12,95%CI = 0.01-0.95,P = 0.02)。
- 单因素分析显示未接受氧疗(OR = 9.18,95%CI = 1.13-74.86,P = 0.03)和贫血(OR = 4.30,95%CI = 1.04-17.78,P = 0.04)与造影剂肾病发生相关。
关键数值与推荐
- 造影剂肾病定义为接触造影剂后48小时内血清肌酐较基线升高≥25%。
- 氧疗方案为造影前吸入纯氧(2 L/min)10分钟。
临床怎么用
- 对拟行心血管造影的肾功能不全患者,可考虑在造影前给予短时纯氧吸入以预防造影剂肾病。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Contrast-induced nephropathy is a complication following coronary angiography and percutaneous coronary intervention. Because contrast-induced nephropathy is a predictor of long-term mortality in patients with ischemic heart disease undergoing percutaneous coronary intervention, preventive strategies are required. We assessed the effects of periprocedural oxygenation on contrast-induced nephropathy among patients with pre-existing renal dysfunction. METHODS: A total of 200 consecutive patients with impaired renal function (estimated glomerular filtration < 60 ml/min per 1.73 m2) undergoing elective cardiovascular angiography were randomly assigned to an oxygenation treatment (n = 100) or control group (n = 100). In oxygenation treatment, pure oxygen (2 L/min) was administered for 10 minutes before exposure to contrast medium. The primary endpoint was the incidence of contrast-induced nephropathy, defined as a ≥ 25% increase in serum creatinine levels from baseline within 48 hours of exposure. RESULTS: In the oxygenation treatment group, partial pressure of arterial oxygen was higher (135 ± 25 mm Hg vs. 84 ± 10 mm Hg, P < 0.001); contrast-induced nephropathy incidence was lower (1% vs. 8%, odds ratio [OR] = 0.12, 95% confidence interval [CI] = 0.01-0.95, P = 0.02); and partial pressure of arterial carbon dioxide and bicarbonate base lactate levels were similar compared with those in the control group. Upon univariate analysis, excess and absence of oxygenation treatment (OR = 9.18, CI = 1.13-74.86, P = 0.03) and anemia (OR = 4.30, CI = 1.04-17.78, P = 0.04) were shown to be associated with contrast-induced nephropathy incidence. CONCLUSION: Oxygenation, a simple, nonpharmacological strategy, may be beneficial when using contrast media in patients with impaired renal function from noninvasive angiography to emergency catheterization.
引用
- Sekiguchi H, Ajiro Y, Uchida Y, et al. Contrast-Induced Nephropathy and Oxygen Pretreatment in Patients With Impaired Renal Function. Kidney Int Rep. 2017. PMID: 29340315. doi:10.1016/j.ekir.2017.08.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。